top of page
Venous diseases, including deep vein thrombosis (DVT), venous insufficiency, and venous ulcers, affect millions of people worldwide and represent a significant healthcare burden.
OsciFlex’s mission is to combat immobility-related venous disease by developing solutions that support healthy blood flow, reduce complications, and improve quality of life.
Immobility is a leading contributing factor for venous disease
There are 300,000-600,000 DVTs per year in the US, most in hospitals.
Chronic venous disease affects more than 25 million Americans
DVT is aLEADING cause of preventable hospital deaths in the US (~100,000/year).
Venous disease costs the US Healthcare System $50-$70 billion annually
FAQ
bottom of page